Clinical Trial Update: Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating losartan for diffuse myocardial fibrosis in patients with sickle cell disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Myocardial Fibrosis
• Sickle Cell Disease

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Sickle Cell Disease, Diffuse Myocardial Fibrosis | Phase 2 | Status: RECRUITING